Baxter International Inc (BAX) stock price, news and key stats
Price
Last close as of Sep 16, 2026. Delayed data; not a live quote.
- Previous close
- $23.71
- Open
- $23.76
- Day range
- $23.18 – $23.86
- Volume
- 9.5M
About Baxter International Inc
Baxter International Inc. is a healthcare company, primarily exposed to the development and supply of medical products, including IV bags.
Latest BAX news
- Smart Infusion Pumps Market Outlook Highlights Strategic Opportunities Across The IndustryMarket Outlook · Aug 26, 2026
The smart infusion pumps market is poised for significant growth, driven by advancements in technology and increasing demand for patient safety in healthcare settings. Baxter International Inc. recently presented compelling real-world data at the American Society of Health-System Pharmacists (ASHP) 2025 Midyear Clinical Meeting, underscoring the advantages of integrating smart infusion systems into clinical practice. These systems are designed to enhance medication delivery accuracy, reduce the risk of errors, and improve overall patient outcomes, making them an attractive investment for healthcare providers. As hospitals and clinics increasingly prioritize patient safety and operational efficiency, the adoption of smart infusion pumps is expected to accelerate. Market analysts anticipate that this trend will create strategic opportunities for manufacturers and technology providers in the healthcare sector. Companies that can innovate and offer integrated solutions, such as real-time monitoring and data analytics, are likely to gain a competitive edge. Furthermore, the growing emphasis on value-based care may drive healthcare institutions to invest in advanced technologies that demonstrate clear benefits in patient management and cost reduction. The implications for the market are significant, as stakeholders from various segments—including manufacturers, healthcare providers, and investors—look to capitalize on this burgeoning demand. With the potential for regulatory support and increased funding for healthcare technology, the smart infusion pumps market is set to expand, presenting a fertile ground for strategic partnerships and investments.
- Non-PVC IV Bags Market Outlook Signals Expansion To $3.79 Billion Through 2030Market Outlook · Aug 19, 2026
The non-PVC IV bags market is projected to experience significant growth, reaching an estimated value of $3.79 billion by 2030. This expansion is driven by increasing demand for safer and more environmentally friendly alternatives to traditional PVC bags, particularly in healthcare settings where patient safety is paramount. The shift towards non-PVC materials is largely influenced by rising awareness of the potential health risks associated with phthalates and other harmful chemicals found in PVC. Market analysts attribute this growth to several factors, including the rising incidence of chronic diseases that require intravenous therapies, an aging population, and advancements in medical technology. Additionally, regulatory pressures and a growing emphasis on sustainability are prompting healthcare providers to adopt non-PVC solutions. As hospitals and clinics seek to enhance patient care while adhering to environmental standards, the demand for non-PVC IV bags is expected to accelerate. Investors and manufacturers in the healthcare sector should closely monitor this trend, as the transition to non-PVC products could reshape supply chains and influence pricing strategies. Companies that innovate in this space may find themselves at a competitive advantage, particularly as healthcare facilities increasingly prioritize safety and sustainability in their procurement processes.
- Nanofiber Materials For Biomedical Market Report 2026 Market Outlook Supported By A Forecast 23.2% CAGRMarket Outlook · Aug 19, 2026
The biomedical market for nanofiber materials is projected to experience significant growth, with a compound annual growth rate (CAGR) of 23.2% anticipated through 2026. This surge is driven by increasing demand for advanced medical applications, including drug delivery systems, tissue engineering, and wound healing products. The unique properties of nanofibers, such as high surface area-to-volume ratios and tunable porosity, make them ideal for enhancing the performance of biomedical devices and therapies. Key market players are focusing on research and development to innovate and improve nanofiber production techniques, which is expected to further bolster market expansion. The rising prevalence of chronic diseases and an aging population are also contributing factors, as healthcare providers seek more efficient and effective treatment options. Additionally, collaborations between academic institutions and industry leaders are likely to accelerate the commercialization of nanofiber technologies. Investors and stakeholders in the biomedical sector should closely monitor this market trend, as the growing adoption of nanofiber materials could lead to significant advancements in patient care and treatment outcomes. The robust growth forecast indicates a promising landscape for companies involved in the development and manufacturing of these materials, potentially reshaping the future of biomedical applications.
Index membership
- S&P 500 · Health Care
Related Health Care stocks
Chart, AI research and agents for BAX
Open BAX in Watchgar for the live chart, AI-graded news, insider and institutional flow, and automated trading agents. Free to start, no card required.
Open BAX in Watchgar